Moorepark Food Research Centre, Teagasc, Moorepark, Fermoy, Co. Cork P61 C996, Ireland; National Institute for Cellular Biotechnology, Dublin City University, D09 NR58, Ireland.
Animal and Bioscience Research Centre, Teagasc Grange, Dunsany, Co. Meath C15 PW93, Ireland.
Animal. 2021 Jan;15(1):100039. doi: 10.1016/j.animal.2020.100039. Epub 2020 Dec 10.
Increasing the content of polyunsaturated fat in the human diet is a priority for reducing cardiovascular disease and cancer risks. Beef has the potential to contribute to the polyunsaturated fat content in the human diet; however, ruminants cannot synthesise many long-chain fatty acids de novo; they require dietary supplementation. The objectives of the current study were to evaluate (i) the effect of a partially rumen protected n-3 long-chain polyunsaturated fatty acid (LC-PUFA) dietary supplement on the fatty acid composition of muscle (Longissimus dorsi), adipose and liver tissues of beef heifers and (ii) the usefulness of blood plasma as a predictor of tissue concentrations of specific fatty acids. Charolais crossbred heifers (n = 20) were assigned to one of two isolipid dietary treatments namely palmitic acid (control) or an n-3 LC-PUFA supplement for a 91-day period. Blood plasma and adipose tissue samples were taken to determine the temporal effect of these diets on fatty acid composition (days 0, 10, 35 and 91), while liver and muscle samples were taken following slaughter. Dietary lipid source did not influence animal growth rate or body condition score. At day 91, the percentage differences between control and n-3 LC-PUFA heifers in concentrations of eicosapentaenoic acid were +61, +176 and +133 % in liver, muscle and adipose, respectively. For docosahexaenoic acid, at the same time point, the percentage differences were +57, +73 and +138 % for liver, muscle and adipose, respectively. Medium-to-strong positive correlation coefficients were evident for liver and plasma fatty acids, in particular, there were positive relationships with concentrations of total saturated fatty acid (SFA), total n-6 PUFA and total n-3 PUFA. This trend also extended to both the ratio of PUFA to SFA (slope (β) = 0.56 ± 0.167, intercept (β) = 0.56, R = 0.61, P < 0.05) and the ratio of n-6 to n-3 PUFA (β = 0.15 ± 0.054, β = 0.24, R = 0.52, P < 0.05). A strong correlation was also detected in the ratio of n-6 to n-3 in plasma and muscle tissue of heifers fed the n-3 LC-PUFA diet (β = 0.53 ± 0.089, β = -0.31, R = 0.83, P < 0.001). The results of this study show that the n-3 LC-PUFA can be readily increased through targeted supplementation and that plasma concentrations of n-3 LC-PUFA are useful predictors of their concentrations in a number of economically important tissues.
增加人类饮食中多不饱和脂肪的含量是降低心血管疾病和癌症风险的首要任务。牛肉有可能增加人类饮食中多不饱和脂肪的含量;然而,反刍动物不能从头合成许多长链脂肪酸;它们需要膳食补充。本研究的目的是评估(i)部分保护的反刍动物 n-3 长链多不饱和脂肪酸(LC-PUFA)膳食补充剂对肉牛肌肉(背最长肌)、脂肪和肝脏组织脂肪酸组成的影响,以及(ii)血浆作为组织中特定脂肪酸浓度预测因子的有用性。夏洛来杂交小母牛(n = 20)被分配到两种等脂饮食处理之一,即棕榈酸(对照)或 n-3 LC-PUFA 补充剂,为期 91 天。在 0、10、35 和 91 天时,采集血浆和脂肪组织样本,以确定这些饮食对脂肪酸组成的时间效应,而在屠宰后采集肝脏和肌肉样本。膳食脂质来源不影响动物生长速度或身体状况评分。在第 91 天,与对照相比,n-3 LC-PUFA 小母牛的肝脏、肌肉和脂肪中二十碳五烯酸浓度差异分别为+61%、+176%和+133%。对于二十二碳六烯酸,在同一时间点,肝脏、肌肉和脂肪中的差异百分比分别为+57%、+73%和+138%。肝脏和血浆脂肪酸之间存在中等至强正相关系数,特别是与总饱和脂肪酸(SFA)、总 n-6 PUFA 和总 n-3 PUFA 的浓度呈正相关。这种趋势也延伸到了多不饱和脂肪酸与饱和脂肪酸的比例(斜率(β)= 0.56 ± 0.167,截距(β)= 0.56,R = 0.61,P < 0.05)和 n-6 与 n-3 PUFA 的比例(β = 0.15 ± 0.054,β = 0.24,R = 0.52,P < 0.05)。在饲喂 n-3 LC-PUFA 饮食的小母牛的血浆和肌肉组织中,n-6 与 n-3 的比例也检测到了很强的相关性(β = 0.53 ± 0.089,β = -0.31,R = 0.83,P < 0.001)。本研究结果表明,n-3 LC-PUFA 可以通过有针对性的补充来增加,并且血浆中 n-3 LC-PUFA 的浓度是许多经济上重要的组织中 n-3 LC-PUFA 浓度的有用预测因子。